Categories AlphaGraphs, Earnings, Health Care

Bristol Myers Squibb (BMY) Q4 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2021 earnings results today.

Total revenues increased 8% year-over-year to $12 billion, driven by Eliquis, Immuno-Oncology and new product portfolios.

Net earnings attributable to Bristol Myers Squibb was $2.4 billion, or $1.07 per share, compared to a net loss of $10 billion, or $4.45 per share, in the same period a year ago. Adjusted net earnings was $4.1 billion, or $1.83 per share.

For the full year of 2022, worldwide revenues are expected to be approx. $47 billion. GAAP EPS is estimated to be $3.37-3.67 while adjusted EPS is estimated to be $7.65-7.95.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%

Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss

Key metrics from Nike’s (NKE) Q2 2025 earnings results

NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net

FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips

Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top